Overview

Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma

Status:
Unknown status

Trial end date:
2017-10-01

Target enrollment:

Participant gender:

Summary

According to amendment 3 this study addresses the question if intensification of administration of rituximab in standard treatment for patients with newly diagnosed aggressive B-Non Hodgkin Lymphoma (B-NHL) and high risk (aaIPI 2 or 3) results in a better time to treatment failure (TTTF)

Phase:

Phase 3

Details

Lead Sponsor:

German High-Grade Non-Hodgkin's Lymphoma Study Group

Collaborator:

Deutsche Krebshilfe e.V., Bonn (Germany)

Treatments:

Rituximab